Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study

Author： Martin-Richard M.   Gallego R.   Pericay C.   Foncillas J.   Queralt B.   Casado E.   Barriuso J.   Iranzo V.   Juez I.   Visa L.   Saigi E.   Barnadas A.   Garcia-Albeniz X.   Maurel J.  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.31, Iss.6, 2013-12, pp. : 1573-1579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

By Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 353-357

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer

By Lee K.-W.   Park S.   Oh D.-Y.   Park Y.-I.   Khosravan R.   Lin X.   Lee S.-Y.   Roh E.-J.   Valota O.   Lechuga M.   Bang Y.-J.  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1547-1558

Springer Publishing Company

Access to resources Recommend Favorite

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study

By von Delius Stefan   Eckel Florian   Wagenpfeil Stefan   Mayr Martina   Stock Konrad   Kullmann Frank   Obermeier Florian   Erdmann Johannes   Schmelz Renate   Quasthoff Stefan   Adelsberger Helmuth   Bredenkamp Rainer   Schmid Roland   Lersch Christian  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

By Tsavaris Nicolas   Kosmas Christos   Skopelitis Helias   Gouveris Panagiotis   Kopteridis Petros   Loukeris Dioynissis   Sigala Frantzeska   Zorbala-Sypsa Alexandra   Felekouras Evangelos   Papalambros Efstathios  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite

A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane

By Ajani J.   Safran H.   Bokemeyer C.   Shah M.   Lenz H.-J.   Cutsem E.   Burris H.   Lebwohl D.   Mullaney B.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 441-446

Springer Publishing Company

Access to resources Recommend Favorite